Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2004 1
2005 1
2006 1
2007 2
2008 1
2010 2
2011 1
2012 1
2013 1
2014 1
2016 3
2017 1
2019 1
2020 3
2022 4
2023 1
2024 4
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Physicochemical stability of bortezomib solutions for subcutaneous administration.
Gómez Á, Benéitez García MC, Barrueco N, Lucena-Campillo MA, López-Lunar E, García-Díaz B, Vicario-de-la-Torre M, Escobar-Rodríguez I, Gil-Alegre ME. Gómez Á, et al. Among authors: escobar rodriguez i. Sci Rep. 2024 Apr 18;14(1):8975. doi: 10.1038/s41598-024-58473-1. Sci Rep. 2024. PMID: 38637597 Free PMC article.
[Linezolid-related leukocytoclastic vasculitis].
Sáez de la Fuente J, Escobar Rodríguez I, Perpiñá Zarco C, Bartolomé Colussi M. Sáez de la Fuente J, et al. Among authors: escobar rodriguez i. Med Clin (Barc). 2005 Apr 30;124(16):639. doi: 10.1157/13074401. Med Clin (Barc). 2005. PMID: 15871789 Spanish. No abstract available.
Effect of early administration of dexamethasone in patients with COVID-19 pneumonia without acute hypoxemic respiratory failure and risk of development of acute respiratory distress syndrome: EARLY-DEX COVID-19 trial.
Franco-Moreno A, Acedo-Gutiérrez MS, Casado-Suela MÁ, Labrador-San Martín N, de Carranza-López M, Ibáñez-Estéllez F, Hernández-Blanco C, Jiménez-Torres J, Vallejo-Maroto I, Romero-Pareja R, Peña-Lillo G, Escobar-Rodríguez I, Torres-Macho J; EARLY-DEX COVID-19 Research Group. Franco-Moreno A, et al. Among authors: escobar rodriguez i. Front Med (Lausanne). 2024 Jul 17;11:1385833. doi: 10.3389/fmed.2024.1385833. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39086948 Free PMC article.
[Pharmacoeconomic aspects of lopinavir/ritonavir monotherapy].
Escobar Rodríguez I, Esteban Alba C. Escobar Rodríguez I, et al. Enferm Infecc Microbiol Clin. 2008 Dec;26 Suppl 16:47-51. doi: 10.1016/s0213-005x(08)76611-4. Enferm Infecc Microbiol Clin. 2008. PMID: 19572445 Review. Spanish.
Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study'.
Calvo-Aranda E, Cañamares-Orbis I, Novella-Navarro M, Martinez-Alcala A, Ortega de la O MDC, Escobar-Rodriguez I, Sanchez-Aranda FM. Calvo-Aranda E, et al. Among authors: escobar rodriguez i. Ann Rheum Dis. 2023 Feb;82(2):e34. doi: 10.1136/annrheumdis-2020-219479. Epub 2020 Dec 14. Ann Rheum Dis. 2023. PMID: 33318061 No abstract available.
Reply letter to the editor concerning the article 'Safety of Sars-Cov-2 vaccines administration for adult patients with hereditary fructose intolerance'.
Izquierdo-Garcia E, Alvaro Alonso EA, Montero Pastor B, Such Díaz A, Escobar Rodríguez I. Izquierdo-Garcia E, et al. Among authors: escobar rodriguez i. Hum Vaccin Immunother. 2022 Nov 30;18(5):2051414. doi: 10.1080/21645515.2022.2051414. Epub 2022 Mar 31. Hum Vaccin Immunother. 2022. PMID: 35358012 Free PMC article.
27 results